GSK Nears $1 Billion Deal for Biotech Company IDRx
GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...
Hosted on MSN2d
FDA awards GSK breakthrough status for relapsed osteosarcoma treatment
"FDA awards GSK breakthrough status for relapsed osteosarcoma treatment" was originally created and published by ...
Cure Today1d
FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
FierceBiotech23d
Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh's preclinical drug
Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical drug. The Big Pharma already has efinopegdutide, a dual GLP-1 ...
Why Viking Therapeutics Stock Plummeted by 24% in December
Viking Therapeutics ( VKTX -2.05%) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's ...
AOL8d
Should You Buy the Dip on This High-Flying Stock?
It penned an agreement with Hansoh Pharma, a China-based pharmaceutical company, to develop HS-10535, a pre-clinical oral GLP-1 weight loss candidate. Merck will obtain the exclusive license to ...
The Pharma Letter3d
BRIEF—FDA Breakthrough status for GSK’227 in osteosarcoma
UK pharma major GSK today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate ...
Daily3d
GSK bone cancer treatment gets USFDA Breakthrough Therapy Designation
London: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation ...
Health Care Roundup: Market Talk
Find insight on China’s healthcare sector, Wuxi Biologics and more in the latest Market Talks covering the Health Care sector ...